[1]
A. Chhetri, S. Palaian, P. Mishra, A. Saha, and P. Shankar, “Introduction to DOTS strategy and the safety profile of first line antitubercular drugs”, Journal of Institute of Medicine, vol. 28, no. 3, p. 63, Oct. 2007.